Bausch Competitors

Stocks . Germany . 
Stock . Bausch Health Companies
BVF Stock  EUR 6.77  0.14  2.03%   
Bausch Health Companies competes with Japan Asia, Scottish Mortgage, MidCap Financial, Guangdong Investment, and SLR Investment; as well as few others. The company classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. Analyzing Bausch Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bausch Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Bausch Health Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bausch Health competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
3.416.7710.13
Details
Intrinsic
Valuation
LowRealHigh
2.395.759.11
Details
Naive
Forecast
LowNextHigh
4.237.5910.95
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.586.537.48
Details

Bausch Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bausch Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bausch and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bausch Health Companies does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ZSL
+ 0.93
1IZ1
55O1
+ 0.88
1IZ1
ZSL
+ 0.84
55O1
GUG
+ 0.56
2WI
55O1
+ 0.44
JAN
1IZ1
+ 0.42
2WI
  
High negative correlations   
GUG
- 0.46
JAN
WIJ
- 0.45
55O1
WIJ
- 0.41
1IZ1
WIJ
- 0.33
ZSL
JAN
- 0.26
2WI
WIJ
- 0.12
JAN

Risk-Adjusted Indicators

There is a big difference between Bausch Stock performing well and Bausch Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bausch Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Bausch Health Competitive Analysis

The better you understand Bausch Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bausch Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bausch Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BVF 2WI JAN 1IZ1 55O1 GUG ZSL WIJ
 2.03 
 6.77 
Bausch
 5.56 
 0.02 
Yunnan
 1.50 
 1.31 
Japan
 0.37 
 13.40 
Scottish
 2.45 
 13.51 
MidCap
 2.82 
 0.69 
Guangdong
 0.71 
 16.74 
SLR
 1.69 
 174.00 
WILLIS
Market Volatility
(90 Days Market Risk)
Slightly risky
Out of control
Risky
Very steady
Very steady
Abnormally volatile
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Insignificant
Weak
Solid
Modest
OK
Good
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Quite High
Above Average
Quite High
Average
Low
Low
Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Over Valued
Under Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Cautious Hold
Strong Buy
Strong Hold
Strong Sell
Buy
Sell
Current Ratio
1.09 X
1.02 X
9.56 X
0.75 X
N/A
3.21 X
1.08 X
5.09 X
Net Asset
29.2 B
48.43 B
20.23 B
N/A
2.6 B
130.03 B
2.54 B
N/A
Profit Margin
(0.03) %
(0.22) %
0.04 %
N/A
N/A
0.18 %
0.03 %
(0.02) %
EBITDA
2.55 B
1.14 B
995 M
N/A
N/A
10.89 B
N/A
170.69 M
Operating Margin
0.18 %
0.03 %
(0.02) %
1.01 %
N/A
0.25 %
0.68 %
0.28 %
Current Valuation
22.26 B
4.02 B
3.24 M
25.26 B
N/A
10.08 B
911.73 M
N/A
Price To Book
18.34 X
0.06 X
0.58 X
N/A
0.85 X
1.15 X
0.80 X
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
3.15 %
7.28 %
N/A
Beta
1.06
0.47
1.51
0.7
N/A
0.51
1.14
1.06
Number Of Employees
19.9 K
7 K
40
8
N/A
10.24 K
6
229
Shares Outstanding
361.87 M
1.19 B
17.7 M
N/A
N/A
6.54 B
54.77 M
6.1 M
Cash Flow From Operations
1.43 B
(2.82 B)
(145 M)
(85.91 M)
(2.68 M)
(4.94 B)
91.06 M
93.3 M
Annual Yield
N/A
0.19 %
N/A
N/A
0.20 %
0.08 %
0.11 %
N/A
Total Debt
22.65 B
7.97 B
8.86 B
1.24 B
N/A
21.81 B
593.27 M
1.91 B
Return On Equity
-1.88
-0.15
0.0627
-0.49
N/A
0.0954
0.0059
-0.0167
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
0.6
N/A
Return On Asset
0.0338
0.0017
-0.0019
-0.27
N/A
0.0386
0.0298
0.0207
Book Value Per Share
(1.91) X
4.35 X
444.83 X
8.42 X
N/A
6.81 X
18.37 X
58.83 X
Total Asset
29.2 B
48.43 B
20.23 B
N/A
2.6 B
130.03 B
2.54 B
N/A
Debt To Equity
880.60 %
194.10 %
232.70 %
0.07 %
N/A
19.90 %
64.00 %
4.58 %
Target Price
35.82
N/A
N/A
N/A
N/A
N/A
20.07
N/A
Last Dividend Paid
N/A
N/A
N/A
0.037
N/A
0.61
1.64
N/A
Shares Owned By Institutions
81.80 %
N/A
11.36 %
9.21 %
N/A
19.14 %
34.61 %
34.43 %
Market Capitalization
3.11 B
52.33 M
30.96 M
N/A
759.02 M
6.13 B
761.34 M
322.79 M
Price To Earning
3.37 X
4.13 X
21.12 X
2.41 X
N/A
19.45 X
10.44 X
297.30 X
Price To Sales
0.32 X
0.01 X
0.01 X
N/A
11.72 X
0.26 X
4.75 X
N/A
Net Income
(225 M)
(888.29 M)
19 M
(2.54 B)
82.36 M
4.7 B
18.34 M
(4.52 M)
Earnings Per Share
0.71 X
(0.14) X
N/A
(2.08) X
N/A
0.09 X
0.13 X
(3.09) X
Shares Owned By Insiders
3.27 %
2.53 %
30.37 %
3.55 %
N/A
56.61 %
7.38 %
61.93 %
Revenue
8.12 B
5.28 B
3.2 B
(7.48 B)
N/A
29.72 B
28.32 M
293.02 M
Cash And Equivalents
782 M
305.92 M
81.9 M
212.13 M
N/A
2.14 B
258.76 M
16.45 M
Cash Per Share
2.22 X
0.26 X
4.63 X
0.15 X
N/A
0.33 X
6.12 X
2.64 X
Gross Profit
5.76 B
1.32 B
1.23 B
(2.4 B)
N/A
11.64 B
139.35 M
248.4 M
Day Typical Price
6.77
0.019
1.31
13.4
13.59
0.69
16.74
174.0
Accumulation Distribution
N/A
N/A
N/A
N/A
0.0175
0.0143
N/A
N/A
Market Facilitation Index
N/A
N/A
N/A
N/A
0.24
0.01
N/A
N/A
Daily Balance Of Power
(9,223,372,036,855)
9.2 T
(9,223,372,036,855)
9.2 T
(1.42)
(2.00)
(9,223,372,036,855)
(9,223,372,036,855)
Period Momentum Indicator
(0.14)
0.001
(0.02)
0.05
(0.34)
(0.02)
(0.12)
(3.00)
Rate Of Daily Change
0.98
1.06
0.98
1.0
0.98
0.97
0.99
0.98
Day Median Price
6.77
0.019
1.31
13.4
13.63
0.7
16.74
174.0
Price Action Indicator
(0.07)
5.0E-4
(0.01)
0.025
(0.29)
(0.01)
(0.06)
(1.50)
Relative Strength Index
44.48
57.64
53.9
63.95
69.14
54.69
68.15
46.23
Coefficient Of Variation
(2,300)
1146.16
2617.91
472.27
903.96
880.04
742.36
(8,395)
Mean Deviation
2.21
7.34
1.1
1.09
0.7791
2.33
0.8457
2.1
Jensen Alpha
(0.15)
1.66
0.0478
0.2847
0.1017
0.358
0.1388
(0.05)
Total Risk Alpha
(0.17)
1.53
0.0382
0.2759
0.0952
0.3356
0.1319
(0.06)
Sortino Ratio
N/A
0.1103
0.0252
0.2044
0.0805
0.1074
0.1466
N/A
Downside Variance
N/A
225.76
3.01
1.88
1.45
10.77
0.8407
N/A
Standard Deviation
3.21
19.17
1.53
1.39
1.01
3.23
1.11
2.87
Kurtosis
2.79
33.58
2.08
0.7176
0.3037
1.45
0.4738
1.33
Potential Upside
3.8
11.43
2.38
2.34
1.8
6.06
2.5
4.49
Treynor Ratio
0.3218
1.84
0.2942
2.45
1.58
(3.10)
1.19
(0.21)
Maximum Drawdown
17.06
147.53
9.57
6.88
4.52
16.49
4.68
15.83
Variance
10.29
367.59
2.35
1.94
1.02
10.46
1.23
8.25
Market Risk Adjusted Performance
0.3318
1.85
0.3042
2.46
1.59
(3.09)
1.2
(0.20)
Risk Adjusted Performance
(0.02)
0.0737
0.0333
0.1603
0.084
0.0912
0.1024
(0)
Skewness
(0.57)
4.73
(0.03)
(0.24)
(0.47)
0.705
0.6922
0.599
Semi Deviation
N/A
8.66
1.34
1.15
0.9745
2.24
0.7246
N/A
Information Ratio
(0.05)
0.0865
0.0284
0.201
0.0959
0.109
0.1212
(0.02)
Value At Risk
(5.41)
(8.11)
(2.24)
(2.02)
(1.91)
(5.19)
(1.44)
(3.82)
Expected Short fall
N/A
(17.82)
(1.46)
(1.23)
(0.85)
(3.71)
(0.96)
N/A
Downside Deviation
N/A
15.03
1.73
1.37
1.21
3.28
0.9169
N/A
Semi Variance
N/A
75.05
1.79
1.33
0.9496
5.01
0.525
N/A

Bausch Health Competition Performance Charts

Five steps to successful analysis of Bausch Health Competition

Bausch Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bausch Health Companies in relation to its competition. Bausch Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bausch Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bausch Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bausch Health Companies, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bausch Health position

In addition to having Bausch Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Information Technology ETFs Thematic Idea Now

Information Technology ETFs
Information Technology ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Information Technology ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Information Technology ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Bausch Stock

When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
How To Invest In Bausch
Details
Is Bausch Stock a good investment?
Details
What is Bausch Health's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Bausch Health Correlation with its peers.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY